Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:3281-3285
Published online before print August 6, 2009, doi: 10.1161/STROKEAHA.109.554055
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/10/3281    most recent
STROKEAHA.109.554055v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pouwels, S.
Right arrow Articles by de Vries, F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pouwels, S.
Right arrow Articles by de Vries, F.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Hip Injuries and Disorders
*Hip Replacement
*Stroke
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Rehabilitation, Stroke
Right arrow Risk Factors for Stroke
Right arrow Epidemiology

(Stroke. 2009;40:3281.)
© 2009 American Heart Association, Inc.


Original Contributions

Risk of Hip/Femur Fracture After Stroke

A Population-Based Case-Control Study

Sander Pouwels, PharmD; Arief Lalmohamed, BSc; Bert Leufkens, PhD; Anthonius de Boer, MD, PhD; Cyrus Cooper, MD, FMedSci; Tjeerd van Staa, MD, PhD Frank de Vries, PhD

From Utrecht Institute for Pharmaceutical Sciences (S.P., A.L., B.L., A.d.B., T.v.S., F.d.V.), Division of Pharmacoepidemiology and Pharmacotherapy, University Utrecht, Utrecht, The Netherlands; MRC Epidemiology Resource Centre (C.C., T.v.S., F.d.V.), University of Southampton, Southampton General Hospital, Southampton, UK; Institute of Musculoskeletal Sciences (C.C.), University of Oxford, Oxford, UK.

Correspondence to Frank de Vries, Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 80082, 3508 TB Utrecht, The Netherlands. E-mail f.devries{at}uu.nl

Background and Purpose— Stroke increases the risk of hip/femur fracture, as seen in several studies, although the time course of this increased risk remains unclear. Therefore, our purpose is to evaluate this risk and investigate the time course of any elevated risk.

Methods— We conducted a case-control study using the Dutch PHARMO Record Linkage System database. Cases (n=6763) were patients with a first hip/femur fracture; controls were matched by age, sex, and region. Odds ratio (OR) for the risk of hip/femur fracture was derived using conditional logistic regression analysis, adjusted for disease and drug history.

Results— An increased risk of hip/femur fracture was observed in patients who experienced a stroke at any time before the index date (adjusted OR, 1.96; 95% CI, 1.65–2.33). The fracture risk was highest among patients who sustained a stroke within 3 months before the index date (adjusted OR, 3.35; 95% CI, 1.87–5.97) and among female patients (adjusted OR, 2.12; 95% CI, 1.73–2.59). The risk further increased among patients younger than 71 years (adjusted OR, 5.12; 95% CI, 3.00–8.75). Patients who had experienced a hemorrhagic stroke tended to be at a higher hip/femur fracture risk compared with those who had experienced an ischemic stroke.

Conclusions— Stroke is associated with a 2.0-fold increase in the risk of hip/femur fracture. The risk was highest among patients younger than 71 years, females, and those whose stroke was more recent. Fall prevention programs, bone mineral density measurements, and use of bisphosphonates may be necessary to reduce the occurrence of hip/femur fractures during and after stroke rehabilitation.


Key Words: bone density • fracture • risk factors • stroke